Network identification

PURI

https://redirect.ema.europa.eu/resource/2309

Network ID

2309

Network name and Acronym

PGRx®

Network countries

France
United Kingdom

Network website

ENCePP partner

Yes
Network description
PGRx®A unique Case-Referent Information Database for the Benefits & Risks of Medicinesis based on a systematisation of the case-referent (or case-control) methodology. PGRx ® is a unique approach to the study of infrequent or delayed events potentially associated with adverse events or beneficial outcomes of drug use (routine collection of 300+ drugs,vaccines and lifestyle factors).In brief,PGRx® collects: 1) Cases of different diseases of interest (MS,Guillain-Barré syndrome,lupus,myositis,RA,diabetes type 1,autoimmune thyroiditis,ITP,Graves disease,Torsade de pointes,first myocardial infarction,depression,suicide attempts,cancer). Cases are recruited from networks of specialised centres in France,UK,Canada,and shortly in and other European countries. 2) A pool of referents representative of patients in general practice (stratified by gender,age and region) is collected by wide networks of GPs. Referents are selected by relevant criteria and matched to the cases.
Network details
Network primary therapeutic area:
Cardiovascular diseases
Disorders of the central nervous system
Endocrine disorders
Gynaecology
Immunological products and vaccines
Immunosuppression
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Paediatrics
Poisoning/Overdose
Psychiatry
Respiratory diseases
Skin disorders
Network funding:
Pharmaceutical company and other private sector 
Non-for-profit organisation (e.g. charity)
Other
EU institutional research programme

Contact

Institutions that are part of this network